Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jun 10.
Published in final edited form as: Blood Red Cells Iron. 2026 Mar 7;2(1):100055. doi: 10.1016/j.brci.2026.100055

Long-Distance Trail Running Induces Inflammatory-Associated Protein, Lipid, and Purine Oxidation in Red Blood Cells

Travis Nemkov 1,*, Emeric Stauffer 2,3,4, Francesca Cendali 1, Daniel Stephenson 1, Elie Nader 2,3, Mélanie Robert 2,3,5, Sarah Skinner 6, Monika Dzieciatkowska 1, Kirk C Hansen 1, Paul Robach 7, Guillaume Y Millet 8,9, Philippe Connes 2,3, Angelo D’Alessandro 1,*
PMCID: PMC13249458  NIHMSID: NIHMS2175592  PMID: 42273167

Abstract

Ultra-endurance running imposes extreme demands on oxygen transport, yet how red blood cells (RBCs) respond at the molecular level remains poorly defined. We integrated plasma and RBC multi-omics with hematology and hemorheology in athletes sampled before and after two trail races of distinct duration: a 40-km marathon (MCC) and a 171-km ultramarathon (UTMB). Both races elicited systemic inflammation, but UTMB was distinguished by marked IL-6 and kynurenine increases, acute-phase protein induction, and profound lipid remodeling. In RBCs, acylcarnitine accumulation, pantothenate depletion, and oxidized lipid species indicated Lands cycle activation, while purine salvage and carboxylate metabolism reflected redox-sensitive rerouting of energy pathways. Proteomics revealed non-random oxidation, particularly methionine oxidation of antioxidant enzymes, metabolic proteins, and proteasome components, correlating with impaired deformability as gleaned by testing of rheological properties. Elevated copper provided an additional correlate of reduced RBC mechanics. Despite minimal signatures of intravascular hemolysis, plasma bilirubin and hypoxanthine rose, consistent with extravascular clearance of damaged RBCs. Collectively, these results demonstrate that ultra-running accelerates RBC aging through inflammatory and oxidative pathways beyond mechanical trauma, linking systemic cytokine responses to molecular lesions, biomechanical dysfunction, and splenic sequestration. These findings not only identify actionable biomarkers of exercise-induced hemolysis but also provide translational insight into oxidative lesions that similarly limit RBC survival in transfusion and inflammatory disease settings.

Keywords: Red blood cell, oxidative stress, inflammation, endurance exercise, metabolomics, deformability

Visual abstract

graphic file with name nihms-2175592-f0008.jpg

INTRODUCTION

Endurance exercise places significant demands on the oxygen transport system, and red blood cells (RBCs) are at the forefront of meeting these challenges. In addition to delivering oxygen and removing carbon dioxide, RBCs contribute to pH buffering and release signaling molecules - such as ATP and nitric oxide - that facilitate vasodilation and enhance muscle perfusion1,2. While moderate exercise is associated with improved cardiovascular function and metabolic health, prolonged endurance events, like marathons and ultramarathons, impose additional mechanical, metabolic, and oxidative stresses. These stressors can result in acute cellular damage particularly in RBCs, where the capacity for repair is limited owing to the lack of nuclei and organelles that results in the incapacity to replace damaged protein and lipid components through de novo synthesis3.

Historically, investigations into exercise physiology have largely focused on skeletal muscle4, serum5, and plasma6 biomarkers to gauge the systemic impact of prolonged running. However, emerging evidence suggests that the RBC compartment provides critical insights into the cellular adaptations and injury responses elicited by extreme exercise7,8. Yet, classic concepts like foot-strike hemolysis - also known as march hemoglobinuria, first described by Fleischer in 18819 - have been recently challenged in comprehensive reviews10, which indicates an incomplete understanding of the role of RBC biology in exercise tolerance and performance. Recent advances in multiomics technologies have opened new avenues for comprehensively mapping the molecular responses to strenuous exercise. Simultaneous interrogation of the metabolome, lipidome, proteome, and metallome, enables holistic understanding of how tissues and circulating cells respond to exercise-induced stress. Studies have highlighted that transient cytokine release (e.g., interleukin-6) during endurance exercise triggers metabolic remodeling and tissue repair11,12, in addition to oxidative modifications in RBC, shifts in membrane lipid composition, and, ultimately, compromised RBC deformability7.

Despite these advances, the specific molecular responses of RBCs to prolonged endurance exercise remain insufficiently characterized. This knowledge gap is particularly relevant in the context of long-distance trail running, where additional challenges such as variable terrain, altitude, and prolonged mechanical stress further compound the injury and repair processes in RBCs. Indeed, long distance running results in appreciable damage to RBC including decreased deformability and increased markers of senescence13,14 in the face of increased inflammation15. Previous omics-based studies have predominantly focused on plasma responses to acute exercise or short-duration laboratory tests16, ultramarathon treadmill simulations17, or in situ18,19, which cannot recapitulate the unique stressors encountered during ultra-endurance events in the outdoors20. Moreover, while plasma-based analyses provide valuable systemic information, they do not capture the direct impact on RBCs - cells that lack nuclei and organelles and are thus uniquely dependent on metabolic pathways to cope with oxidative damage.

In light of these considerations, our study was designed to integrate multi-omics approaches to delineate the impact of long-distance trail running on both plasma and RBC molecular signatures. By comparing pre- and post-race samples from athletes competing in the World Class Martigny-Combes à Chamonix race (MCC, 40 km, elevation gain: 2,300 m) and Ultra-Trail du Mont Blanc race (UTMB©, 171 km, elevation gain: 10,000 m), we aimed to elucidate the distinct metabolic, inflammatory, and oxidative modifications that occur with increasing exercise duration. We hypothesized that while both marathon and ultramarathon events trigger systemic inflammatory responses and metabolic remodeling, the extent of cellular damage -particularly within the RBC compartment - would be more pronounced in ultramarathon running.

MATERIALS and METHODS

Sample Collection, Hematological, and Hemorheological Measurements:

Blood samples were collected from endurance-trained participants before and immediately after either a 40 km trail race (MCC) or a 171 km ultra-trail (UTMB). The protocol was approved by the CPP Ouest VI Ethics Committee and conducted in accordance with the Declaration of Helsinki. Standardized assessments included hematological and hemorheological parameters (blood viscosity, red blood cell [RBC] deformability and aggregation, plasma free hemoglobin, microparticle release, phosphatidylserine exposure) and inflammatory markers such as IL-6, as previously described.14

Omics analyses:

Metabolomics and lipidomics,21,22 ICP-MS23 and proteomics analyses24 were performed as previously described and extensively detailed in Supplementary Methods. Graphs, heat maps and statistical analyses (either T-Test or ANOVA), multivariate analyses including Principal Component Analysis (PCA), Partial Least Squares-Discriminant Analysis (PLS-DA), hierarchical clustering analysis (HCA), and metabolite pathway enrichment analysis are performed using MetaboAnalyst 5.025 DSPC IL-6 network filtered by degree (1.5), betweenness (1.0), and correlation (p < 0.001) were plotted using CytoScape.26 Proteomics GO networks were prepared using ShinyGO 0.82.27,28

RESULTS

Molecular responses to ultra-running in plasma and RBCs

We profiled paired plasma and RBC samples from 23 runners (MCC, 40 km: n=11; 5 female, 6 male, 35.7 ± 8.6 years; UTMB, 171 km: n=12; 4 female, 8 male, 38 ± 6.4 years) using multi-omics (metabolomics, lipidomics, proteomics, metallomics), and correlated omics results to hemorheology measurements (re-elaborated from Robert et al.14). This dataset encompassed 440 or 1105 proteins, 659 or 647 lipids, 197 or 271 metabolites, and 8 or 6 trace elements in plasma or RBCs, respectively (Figure 1A; Supplementary Figure1AB; Supplementary Tables 12).

Figure 1. Multiomics of a 40 km or 171 km Run.

Figure 1

(A) Plasma and RBC were taken before (Pre) and after (Post) a 40-km (Martigny-Combes à Chamonix race, MCC) or 141-km (Ultra-Trail du Mont Blanc, UTMB©) footrace. (B) Proteomics, lipidomics, metabolomics using liquid chromatography mass spectrometry (LC-MS), and metalomics using ion coupled plasmon (ICP)-MS were collected. (B) Partial Least Squares Discriminant Analysis (PLS-DA) of the plasma fraction during the MCC and (C) UTMB along with associated volcano plots highlighting all analytes with fold change (FC) > 1.5 and p-value < 0.05 from a paired T-test. (D) PLS-DA of the RBC fraction during the MCC and (E) UTMB along with associated volcano plots highlighting all analytes with fold change (FC) > 1.5 and p-value < 0.05 from a paired T-test. (F) Average speed (in kilometers per hour) for all runners in each race. (G) Linear mixed model adjusted for age, sex, BMI of runner speed (km/h) in the plasma, or (H) RBC fraction.

Pre- and post-race plasma profiles separated cleanly in both races (Figure 1BC). The MCC was characterized by increases in acylcarnitines and fatty acids, consistent with enhanced β-oxidation and mobilization of lipid substrates. By contrast, UTMB plasma displayed decreases in lysophospholipids and higher levels of hypoxanthine, creatine kinase (KCRM), and acute-phase proteins (CRP, SAA1/2), pointing to metabolic stress and tissue damage. RBCs paralleled these differences: MCC samples accumulated acylcarnitines and fatty acids while pantothenate decreased, suggesting higher flux through CoA-dependent repair pathways; UTMB samples contained hydroxylated acylcarnitines, the oxidized linoleate derivative 13(S)-HODE, and kynurenine (Figure 1DE). Of note, RBC samples after UTMB, but not MCC, showed increases in biliverdin and bilirubin (Figure 1E). Since RBCs are devoid of heme oxygenase, these observations are consistent with non-enzymatic heme breakdown by oxidation into both biliverdin IXα and β isoforms29, which can then be converted by BLVRB – abundant in the RBC cytosol30 – into bilirubin. However, it must be acknowledged that our high-throughput method does not resolve biliverdin isomers.

Performance metrics also diverged. Runners averaged 6.1 km/h in MCC vs 4.4 km/h in UTMB, mirroring the longer distance in the latter race (p=0.009; Figure 1F). A linear mixed model identified 51 plasma molecules significantly associated with speed, spanning multiple lipid classes and tryptophan catabolites, while only RBC ADP correlated with pace (Figure 1GH). Volcano plots of correlations to speed, unadjusted or adjusted by elevation gains (vertical speed) are shown in Supplementary Figure 1. Thus, plasma captured dynamic adjustments to workload, whereas RBCs recorded the integrated oxidative and metabolic burden of the entire race

Inflammatory remodeling dominates the plasma response

Plasma lipidomics revealed decreases in diacylglycerides across both races, with additional UTMB-specific decreases in lysophosphatidylcholines (LPC), lysophosphatidylethanolamines (LPE), and cardiolipins (CL), alongside robust acylcarnitine accumulation (Figure 2A) These changes are consistent with sustained mitochondrial lipid remodeling and altered membrane turnover. Pathway modeling highlighted distinct remodeling strategies: MCC runners had increased fatty acid transporter and immunomodulator CD3631; UTMB favored phosphatidylserine and ether-lipid axes, whereas MCC emphasized phosphatidylcholine synthesis (Figure 2BC; Supplementary Table 3).

Figure 2. Lipidomics, Proteomics and correlates to the inflammation marker IL-6 after the MCC and UTMB.

Figure 2

(A) Total lipid class quantities shown as log10(Peak area sum) before and after the MCC and UTMB. (B) BioPAN models of lipid class flux during the MCC (left) and UTMB (right). Lipid classes are indicated by node shape where filled nodes indicate significantly modified class. Fluxes normalized by Z-score with positive fluxes shown in teal and negative fluxes shown in purple. (C) A volcano plot showing the intra-subject proteomic fold changes with respect to each race. (D) IL-6 measurements before and after the MCC (blue) and UTMB (red). (E) A Debiased Sparse Partial Correlation (DSPC) network of IL-6. An expanded view is available in Supplementary Figure 2. (F) BioPAN model of lipid pathway flux for lipids significantly associated with IL-6 levels. (G) Metabolite set enrichment analysis for metabolites lipids significantly associated with IL-6 levels. (H) Gene Ontology analyses for proteins positively (left) of negatively (right) significantly associated with IL-6 levels. (I) KEGG pathway enrichment based on proteomics data. (J) Kynurenine correlations between plasma (y-axis) and RBC (x-axis) compartment. (K) RBC molecular correlates with plasma IL-6 levels.

Plasma proteomics showed broader induction after UTMB than MCC. Creatine kinase (KCRM) rose in UTMB runners - reflecting ongoing muscle injury32 - who also had higher increases in acute-phase proteins amyloid proteins (SAA1/2) and Lipopolysaccharide-Binding Protein (LBP) (Figure 2C; Supplementary Figure 1). Circulating cytokines increased after both races15, but IL-6 rose more strongly after UTMB, especially in males (Figure 2D; Supplementary Figure 1C).

An IL-6-centered network integrated these signatures (Figure 2E). IL-6 correlated with acute-phase proteins (CRP, SAA1, SAA4, S100A9), white blood cell counts, tricarboxylic acid intermediates (citrate, succinate, fumarate), purine catabolites (hypoxanthine, urate), fatty acids including arachidonic acid [FA(20:4)] and heterohydroxyeicosatetraenoic acids (HETE), and remodeling of diacylglycerides and lysophosphatidylcholines into phosphatidylcholines (Figure 2F; Supplementary Figure 2). Gene-ontology analyses supported this view, with acute inflammatory response enriched among positively correlated proteins (Figure 2GH), whereas cholesterol trafficking and complement activation were suppressed (Figure 2I).

Kynurenine – a marker of RBC hemolytic fragility observed in RBC blood bank storage33 – emerged as a central metabolite. Its levels correlated strongly with IL-6 across compartments, but RBC kynurenine was the single strongest correlate of IL-6 in the entire dataset (Figure 2JK; Supplementary Figures 34), similar to prior work in SARS-CoV-23436 and Sickle Cell Disease.37 This supports the idea that RBCs act as reservoirs for inflammation-linked metabolites, buffering circulating levels but also becoming more vulnerable to stress.33

RBCs accumulate damage markers with distance and time under load

Hematological parameters revealed reductions in mean cell volume and increases in immature reticulocytes after both races. While RBC only after the MCC had enhanced phosphatidylserine (PS) exposure indicative of eryptosis38, only UTMB triggered a significant increase in RBC-derived extracellular vesicles and a measurable decrease in hematocrit (Figure 3A). Of note, RBC counts and hematocrits decreased significantly after UTMB – but not MCC – both in male and female runners (Figure 3BC). These observations suggest enhanced eryptosis3840 and splenic clearance of damaged cells in the longer race.

Figure 3. RBC Multiomics of Running.

Figure 3

(A) Hematologic parameters of each race is shown. (B) RBC counts (C) and hematocrit by race and sex. (D) PLS-DA of intra-subject normalized molecular values for each race. (E) The top 25 molecules based on Variable Importance in Projection (VIP) for the PLS-DA are shown (left) along with relative values of intra-subject fold changes for each race in the heat map (right).

RBC metabolomes clearly separated by race (Figure 3D). MCC RBCs were enriched in medium chain acylcarnitines and urate, consistent with accelerated lipid turnover and purine catabolism. UTMB RBCs contained long-chain acylcarnitines, dicarboxylic acids (fumarate, methylmalonate), carnitine, and elevated copper (Figure 3E). Together, these findings suggest that distance dictates whether RBCs rely primarily on rapid catabolism (MCC) or engage longer-term oxidative stress adaptations (UTMB).

Membrane repair via the Lands cycle is a shared RBC response

RBC lipid classes reflected widespread remodeling. Acylcarnitines increased and lysophospholipids decreased after both races (Figure 4A), consistent with activation of the Lands cycle (Figure 4B), a process by which RBCs replace oxidatively damaged membrane lipid acyl chains using a pool of acyl-CoA molecules that are interconverted with acylcarnitines based on demand for lipid repair.41 Free fatty acids and acylcarnitines increased in both cohorts (Figure 4CD), while lysophospholipid:phospholipid ratios declined (Figure 4E). The CoA precursor pantothenate decreased in both races, whereas carnitine rose only after UTMB suggesting ongoing utilization of the acyl-CoA pool rather than conversion into acylcarnitines for storage of acyl chains (Figure 4B, F). These changes highlight the reliance of RBCs on acyl pools to replace oxidized membrane lipids.

Figure 4. RBC Lipidomics.

Figure 4

(A) The average peak areas of lipids identified from untargeted analysis were summed according to lipid class and plotted as a heat map. p-values from Two-tailed paired T-test for MCC pre/post comparisons are indicated as *, p<0.05; **, p<0.01, ***, p<0.001; ****, p<0.0001 and p-values for UTMB pre/post comparisons are indicated as +, p<0.05; ++, p<0.01, +++, p<0.001; ++++, p<0.0001. (B) A cartoon of the Lands cycle for red blood cell membrane repair is shown. (C) Average peak areas from semi-targeted analysis for fatty acids and (D) acylcarnitines are shown as heat maps. (E) The ratio of lysophospholipid-to-phospholipid by group from untargeted analysis (F) The levels of pantothenate and carnitine are plotted as violin plots. (G) BioPAN or RBC during the MCC and (H) UTMB are shown. (I) Violin plots of significant oxylipins before and after the MCC (blue) and UTMB (red).

BioPAN lipid networks revealed race-specific pMCC emphasized phosphatidylcholine and ether-lipid remodeling, pathways that support ferroptosis resistance, whereas UTMB showed stronger redistribution toward phosphatidylserine (Figure 4GH; Supplementary Table 4). Oxidized lipid species such as hydroxy- and hydroperoxy-derivatives of linoleate and linolenate increased significantly, especially after MCC (Figure 4I; Supplementary Table 2). Thus, while both races engaged repair mechanisms, UTMB RBCs appeared to preserve phosphatidylserine asymmetry – likely via ATP-dependent flippases or by selective removal of PS-exposing cells – whereas MCC RBCs accumulated oxidized lipid species that may predispose to hemolysis.

Redox-sensitive rerouting toward purine salvage and alternative carboxylate metabolism

Because RBCs lack mitochondria, glycolysis is their sole source of ATP. Lactate accumulated significantly after MCC, while UTMB elicited broader changes in glycolytic intermediates with altered phosphoenolpyruvate:pyruvate ratios suggestive of redox-sensitive pyruvate kinase inhibition42 (Supplementary Figure 5). Such inhibition could theoretically impair ATP production but preserve 2,3-BPG, an allosteric effector that enhances oxygen unloading.

The pentose phosphate pathway, essential for NADPH generation43, was more active after UTMB, supporting oxidative stress management. Purine metabolism bifurcated by distance: MCC RBCs accumulated inosine and urate, consistent with catabolism, whereas UTMB RBCs accumulated IMP and hypoxanthine, consistent with salvage via AMPD344 (Figure 5A). This salvage relies on aspartate, which was also consumed specifically in UTMB RBCs, and was accompanied by increased malate, consistent with NAD+ recycling via the GOT1/MDH axis45 (Figure 5B). Pyruvate:lactate ratios were higher both at baseline and after UTMB compared with MCC, consistent with enhanced methemoglobin reductase activity under oxidant load (Figure 5B), similar to observations in people with G6PD deficiency46,47. Collectively, these data support a shift from purine degradation during the shorter MCC to purine salvage and alternative carboxylate metabolism during the longer UTMB distance.

Figure 5. Purine Salvage and Carboxylate Metabolism in RBC.

Figure 5

Metabolites in the (A) purine salvage or (B) carboxylate metabolism pathways are shown. Individual samples from MCC (O) at Pre (light blue) and Post (dark blue), or UTMB (□) at Pre (light red) or Post (dark red) are shown within violin plots. p-values from Two-tailed homoscedastic T-tests are indicated as *, p<0.05; **, p<0.01, ***, p<0.001; ****, p<0.0001. The pathway map (center) was created with Biorender.com.

Proteome oxidation preferentially targets proteostasis, metabolism, and the cytoskeleton

Proteomic analysis revealed widespread oxidative post-translational modifications. PCA at the peptide/PTM level separated pre- and post-race samples (Figure 6A). Methionine oxidation increased after both races, whereas cysteine carbamidomethylation (reflecting reduced thiols) trended lower after UTMB (Figure 6B). These modifications correlated strongly with rheological parameters: methionine oxidation associated with reduced deformability and an oxidized glutathione ratio, while cysteine carbamidomethylation correlated negatively with IL-6 and adiposity (Figure 6C).

Figure 6. RBC Proteomics demonstrates increased protein oxidation.

Figure 6

(A) Principal Component Analysis (PCA) of RBC peptide-level data. (B) Distribution of post translational modification (PTM) across the proteome. (C) Hive plot of significant Pearson correlations (R) between physiological, hematological, and rheological parameters are shown with R > 0.7 shown in red and R < −0.7 shown in blue. On the right, a labeled plot showing Pearson correlations for values measured at each race/time point (R > 0.7, R < −0.7) with methionine oxidation and cysteine carbamidomethylation. (D) Heat map showing relative peptide abundance across MCC and UTMB. (E) Volcano plot comparing peptide levels in the post MCC and UTMB samples. (F) KEGG Pathway enrichment of proteins with statistically significant (ANOVA Fisher’s LSD FDR < 0.05) enrichment of methionine oxidation.

Oxidation was more pronounced in UTMB RBCs when normalized to total peptide signal (heat map and volcano plot in Figure 6DE, respectively). Pathway enrichment indicated non-random targeting of antioxidant enzymes - including those involved in protein isoaspartyl-damage repair48 (PRDX6, PCMT1, GSTO, GCLM), metabolic enzymes (BPGM, PGD, BLVRB, ACLY), proteasome and ubiquitination machinery49 (UBA1, UBE2V2, PSMC3), and structural proteins (spectrin, ankyrin, band 3) (Figure 6F; Supplementary Figures 67). Notably, proteins shared with neurodegenerative pathways (Parkinson, Huntington, Alzheimer) were enriched, underscoring convergence between RBC oxidative stress and broader proteostatic failure. In an anucleate cell, the inability to replace oxidized proteins magnifies reliance on the proteasome, which itself showed oxidative impairment.

Deformability falls when methionine oxidation and copper rise

RBC deformability, measured as elongation index across shear stresses,14 declined significantly after UTMB but not after MCC (Figure 7A). Correlation analysis revealed that nitrogen-linked metabolites (lysine, proline, xanthine) tracked positively with deformability, whereas glycolytic intermediates (2/3-phosphoglycerate, 2,3-BPG) and hydroxy-acylcarnitines tracked negatively (Figure 7B). Proteins associated with deformability were enriched for proteasome assembly (Figure 7C). While total proteasome subunit levels were unchanged (Figure 7D), methionine oxidation on proteasome components increased during ultrarunning and inversely correlated with deformability (Figure 7E), consistent with oxidation-induced impairment of proteostasis.

Figure 7. Molecular Correlates with RBC Deformability.

Figure 7

(A) Total deformability decreases specifically after UTMB (see Sup Fig for deform on all Pressures). (B) Spearman correlations with Deformability AUC. (C) GO Enrichment terms with deformability. (D) Heatmap showing total levels of proteasome subunits. (E) Dot plot showing the Pearson correlation with RBC deformability on the x-axis. The size of each dot is proportional to the Post/Pre fold change and the dot outline indicates with the fold change increased (red) or decreased (blue) after the race. The significance of the correlation is indicated by color. (F) Pearson correlation at each shear stress pressure for metals, along with (G) abundance before and after each race. (H) Pearson correlation plots of hematocrit and plasma levels of bilirubin and hypoxanthine. Individual races and time points are indicated. (I) A model of RBC damage accumulation during long distance trail running.

Metals provided another dimension. RBC potassium, magnesium, and iron showed variable correlations, but copper levels notably rose after UTMB and consistently correlated inversely with deformability across shear stresses (Figure 7FG). Copper accumulation is a known feature of the acute-phase response,50 and free copper can catalyze lipid peroxidation and impair membrane fluidity in RBC.51 These findings suggest that copper may be both a biomarker and a mediator of impaired RBC mechanics during ultra-endurance stress.

Plasma readouts favor extravascular clearance over intravascular hemolysis

To explain the fall in hematocrit after UTMB, while accounting for the documented expansion of plasma fluid volumes during ultrarunning52, plasma proteomics were re-analyzed without cross run normalization to assess impact of potential changes in total protein abundance. Abundant proteins (albumin, ApoA-I) and electrolytes (sodium, iron, calcium) remained stable, but transferrin decreased after MCC and haptoglobin decreased after both races (Supplementary Figure 8A). A linear mixed model of plasma metabolites linked hematocrit inversely to acetoacetate, but most strongly to bilirubin and hypoxanthine (Figure 7H, Supplementary Figure 8B). Both metabolites increased after UTMB (Figure 7H), consistent with splenic clearance of damaged RBCs rather than frank intravascular hemolysis.53,54

RBC creatinine, a proxy for circulatory age55,56, rose after both races, more prominently after MCC (Supplementary Figure 8D). This result may reflect preferential clearance of younger, less dense cells during the longer distances of the UTMB. Together, these data suggest a model in which prolonged running accelerates oxidative and structural damage, stiffens RBCs, and favors extravascular clearance, as captured in plasma bilirubin and hypoxanthine (Figure 7I).

Several measurements discussed above showed significant correlations with both absolute speed and vertical-efficiency speed (i.e., speed normalized by elevation gain) across the two races (Supplementary Figure 1). Faster runners exhibited higher hematocrit, increased PS+ RBCs, and greater microparticle abundance, consistent with race-associated hemolysis and RBC membrane stress. Speed was also positively associated with plasma hemoglobin, as well as metabolites such as histidine and anthranilate, reflecting enhanced muscle protein turnover and tryptophan–kynurenine pathway activation. In contrast, negative correlations were observed for several proteins of likely muscle origin (e.g., ACTN1, CAP1, FLNA, TPM3, TPM4), suggesting that higher performance levels are accompanied by greater skeletal muscle disruption independent of RBC injury. These trends further support the possibility that circulating biliverdin/bilirubin partially derives from degradation of muscle heme-containing proteins – even though myoglobin (MB) itself was not detected in our plasma proteomics, potentially due to its rapid renal clearance given its monomeric size (16 kDa, i.e., <45 kDa kidney filtration threshold).

In summary, running distance – and thus cumulative inflammatory and oxidative stress – dictated the depth of RBC remodeling. Both races triggered activation of the Lands cycle and proteome oxidation, but only UTMB reached a threshold where methionine oxidation, copper accumulation, and proteostasis bottlenecks translated into measurable declines in deformability and extravascular hemolysis. The integrated plasma and RBC datasets thus connect inflammation to membrane damage, protein oxidation, mechanics, and clearance in vivo, providing a molecular explanation for why ultra-endurance running accelerates RBC aging.

DISCUSSION

This study demonstrates that marathon and ultramarathon trail running elicit a cascade of molecular and rheological changes in red blood cells (RBCs) that extend well beyond mechanical trauma. By integrating multi-omics with hemorheology, we show that systemic inflammation, oxidative stress, and metabolic remodeling act as central drivers of accelerated RBC aging and clearance57. Even a 40 km race (MCC) induced inflammatory signals – leukocytosis, IL-6 elevation, acute-phase protein induction, and kynurenine accumulation – with further amplification during the 171 km ultramarathon (UTMB). These signatures were accompanied by early phosphatidylserine (PS) exposure after MCC and by impaired deformability, cell shrinkage, structural protein oxidation, microparticle generation, and reticulocytosis after UTMB. Although both races elicited inflammatory and metabolic remodeling, the depth and nature of these responses diverged markedly with distance. The shorter MCC distance primarily induced transient metabolic activation characterized by increases in lactate and the early signatures of RBC membrane remodeling revealed by increased oxidative lipid damage, elevated acylcarnitines and fatty acids, and depleted pantothenate. In contrast, the UTMB produced a far more extensive systemic and cellular perturbation, with disproportionately higher IL-6 and kynurenine levels, stronger acute-phase protein induction, and widespread plasma lipid remodeling involving depletion of lysophospholipids. RBCs from UTMB runners accumulated long-chain and hydroxylated acylcarnitines, dicarboxylates, and copper, and exhibited more pronounced activation of the pentose phosphate pathway, redirection toward purine salvage, and increased aspartate consumption; features consistent with sustained oxidative stress. Proteomics further revealed that only UTMB triggered extensive methionine oxidation across antioxidant enzymes, metabolic proteins, and cytoskeletal components, and the proteasome, correlating with impaired deformability. Correspondingly, rheological measurements showed a significant decline in elongation index after UTMB but not MCC, and plasma bilirubin and hypoxanthine rose selectively after UTMB, indicating enhanced extravascular clearance of damaged RBCs. Together, these findings demonstrate that while both events impose metabolic stress, only the ultra-endurance load of the UTMB crosses a threshold at which oxidative injury, proteostatic failure, membrane remodeling, and biomechanical dysfunction converge to accelerate RBC aging and clearance.

Beyond the RBC-intrinsic signatures, the integrated plasma multi-omics data provide essential context for interpreting the cellular phenotypes observed in both races. Plasma metabolomics and lipidomics revealed robust changes consistent with escalating inflammatory and metabolic load, the UTMB-specific depletion of lysophospholipids and cardiolipins, broad acylcarnitine accumulation, and increases in purine degradation products such as hypoxanthine. These circulating shifts paralleled, and likely contributed to, the oxidative and metabolic stress observed within RBCs. For example, the pronounced rise in IL-6 and kynurenine in plasma during UTMB mirrored the accumulation of kynurenine inside RBCs, which emerged as the strongest correlate of IL-6 across the entire dataset thus reinforcing the role of RBCs as reservoirs and buffers of inflammation-linked metabolites. Acute-phase protein induction in plasma (SAA1/2, LBP, CRP) also aligned with increased methionine oxidation of antioxidant enzymes and cytoskeletal proteins within RBCs, suggesting coordinated systemic and cellular oxidation. Likewise, elevated plasma hypoxanthine and bilirubin, consistent with increased purine turnover and extravascular clearance, matched the observed decline in deformability and accumulation of oxidation products in RBCs. These integrated plasma/RBC relationships emphasize that the cellular lesions captured in RBCs do not arise in isolation but reflect a broader systemic inflammatory and metabolic environment shaped by race duration and workload.

The most evident systemic change was a reduction in hematocrit. While some studies have suggested RBC are removed substantially due ultrarunning58,59, use of more direct carbon-monoxide rebreathing techniques that assess total hemoglobin mass and total red blood cell volume after ultrarunning (including the UTMB) have attributed hematocrit alterations to plasma volume expansion of 18–20%52,60. Although hemodilution accounts for part of this decrease, our findings indicate that splenic sequestration and extravascular hemolysis of oxidatively damaged and less deformable RBCs are significant contributors, consistent with increases in bilirubin and decreases in haptoglobin despite minimal intravascular hemolysis, and in keeping with similar findings in the context of transfusion of RBCs after prolonged storage61. Consistent with this hypothesis, plasma levels of bilirubin increased in accordance with decreased hematocrit, and while cell free hemoglobin remained unchanged, haptoglobin was decreased. Once RBCs accumulate sufficient oxidative or mechanical damage, they are cleared by hepatic and splenic macrophages62. During periods of excess RBC removal, indirect bilirubin is released back into circulation rather than removed through the biliary duct and intestine53. Therefore, these results illustrate how extended endurance running exercise results in an accelerated aging process within the RBC population, thereby leading to enhanced removal of damaged cells from circulation.

Running-induced hemolysis is often attributed to repetitive foot-strike trauma.63 Our results highlight additional, non-mechanical lesions, consistent with evidence for supraphysiological oxidant stress in RBCs during exercise64. These mechanisms include alteration of the membrane lipidome7,65, cytoskeleton59,66, and depletion of antioxidant systems67, which occur in conjunction with increased osmotic fragility due, in part, to prolonged exposure to lactate acidosis and subsequent dehydration at higher exercise intensities6872. Indeed, RBCs here decreased in volume and deformability, and while glutathione did not appear to be depleted, protein and lipid oxidation increased substantially.

We observed multiple impacts of running on the RBCs membrane lipidome. RBCs repair membrane lipid damage using the Lands Cycle, which relies on the generation of acyl-CoA substrates to replace damaged acyl chains73. This process is buffered by acylcarnitines, which serve as an ATP-independent source of acyl chains7476. Therefore, carnitine availability can bolster this process and improve RBC function under extreme oxidative stress environments of blood storage77. In this study, however, we observed carnitine accumulation specifically after UTMB, which might suggest that RBCs are utilizing the acyl-CoA pool at an accelerated rate and have less need for storing acyl chains in the acylcarnitine pool. Consistent depletions in both races of the CoA precursor pantothenate (Vitamin B5), which is metabolized by RBCs78,79, suggests alternative strategies to maintain the Lands Cycle during exercise provided that intestinal absorption is optimized80,81.

Double bonds in acyl chains are susceptible to hydroxylation via alpha-oxidation to generate hydroxyacylcarnitines. Inverse correlations between hydroxyacylcarnitines and RBC deformability seen here were also observed in cyclists7, who do not experience similar mechanical stress in the foot, thereby indicating alternative sources of oxidative lipid stress. Notably, these molecules increase in RBC as a function of cardiorespiratory workload in a controlled cardiopulmonary exercise test (CPET) in healthy subjects82. Acylcarnitine hydroxylation may occur in conjunction with increased desaturation of fatty acids, which are subsequently susceptible to lipid peroxidation83. Indeed, fatty acid desaturase activity is upregulated in part to recycle NAD+84. While the role of this pathway has been established in ex vivo RBCs storage85, future work should look at the role this pathway plays in response to exercise in vivo.

The extent of oxidation on proteasome subunits inversely correlated with RBC elongation index, suggesting that the loss of ability to degrade damaged proteins may be linked to loss of deformability, or that deformability itself may influence proteasome activity. Indeed, loss of proteasome activity in conjunction with increasing oxidative stress and decreasing RBC deformability has been observed in ultra-trail running races on La Reunion Island.86 In addition, the levels of copper were consistently inverse correlated with elongation index at all shear stresses. Copper accumulation is known to occur as part of the acute phase response50 and can directly decrease RBC deformability51 through interaction with and subsequent oxidation of membrane phospholipids87. Future work should focus on understanding the source of this copper (i.e. extracellular versus loss of conjugation to copper-containing proteins such as superoxide dismutase, for example), its direct role in RBC function, and how exercise or other stressors influence concentration dynamics.

These results, however, do highlight the importance of oxidative stress management in circulation prior to RBC removal by the reticuloendothelial system. One process by which RBCs are selected for removal involves their ability to traverse the interendothelial slits within the spleen. With sub-1.5 μm diameters, this transit is thus invariably dependent on the RBCs ability to deform88. Moreover, passing through gradients of varying tonicity in both the spleen and kidney requires that the RBCs can maintain resilience to osmotic stress. Interestingly, RBCs that possess high levels of kynurenine are also increasingly fragile to changes in osmotic gradients33. Because kynurenine is not synthesized by RBCs, its abundance is therefore a reflection of the circulating environment. Individuals who donate RBC units with higher levels of kynurenine tend to be of older age or higher BMI, and the plasma proteome within these units is characterized by a sterile inflammatory environment33. This signature is also present in interferon-associated inflammation of Trisomy 2189. In an acutely inflamed environment such as COVID-19, kynurenine is strongly correlated with both IL-6 levels and disease severity34,36,90. Notably, comparable damage to RBC membrane lipids and proteins has been documented in COVID-19 patients91, in line with decreased RBC deformability92,93. These studies, however, were performed using blood from one or two collections and thus represented “snapshots” of individual biology at the time of collection. In this study, we were able to obtain a more dynamic view of this network after paired sampling in the same subjects. Collectively, the association between cell rheology and oxidative damage to proteins and lipids reinforces previous findings, though expands these from therapeutic settings such as blood storage and pathological settings such as COVID-19 to a new setting of prolonged endurance exercise.

The present findings not only confirm that extreme endurance exercise induces a complex cascade of RBC damage and repair processes but also offer mechanistic insights that have broader implications. Repeated exposure to mechanical trauma (e.g., foot-strike hemolysis) and additional circulatory shear stress compounded by metabolic perturbations, appear to trigger oxidative injury that is evident in the accumulation of oxidized proteins (e.g., methionine oxidation) and altered lipid profiles. In addition to these mechanistic insights, our study underscores important differences between running-based endurance activities and other modalities such as cycling. Running, particularly on hard surfaces, uniquely exacerbates mechanical damage to RBCs through repetitive impact forces. In contrast, non-weight-bearing activities predominantly induce shear stress without the added burden of direct mechanical trauma. This distinction is critical when designing training and recovery strategies, including targeted nutritional support (e.g., antioxidants, pantothenate, or carnitine supplementation) or tailored recovery protocols.

Moreover, the multi-omics signatures identified here have direct implications for athletic performance and recovery. The observed decreases in RBC deformability and alterations in metabolite and protein profiles suggest that prolonged endurance exercise challenges the balance between RBC damage and repair. In the short term, this imbalance may impair microcirculatory flow and reduce oxygen delivery, contributing to performance decline during ultramarathons. Over the longer term, repeated bouts of exercise-induced RBC turnover could drive hematological adaptations that, while beneficial (e.g., a younger, more resilient RBC pool), also risk cumulative damage if recovery is insufficient. These insights pave the way for future research aimed at defining an “optimal range” of hemolysis and RBC turnover during exercise – a concept that could be instrumental in developing personalized training and nutritional interventions.

Notably, the molecular signatures identified here parallel those observed in stored RBCs used for transfusion. Storage induces progressive oxidative damage, accumulation of oxidized lipids and proteins, impairment of deformability, and eventual extravascular clearance after transfusion – features strikingly similar to those we observed in ultramarathon RBCs. This convergence underscores that endurance running provides a unique “in vivo stress test” that recapitulates lesions central to transfusion medicine.

Like for recent advances in precision transfusion medicine,94 inter-individual variability, driven by factors such as age, sex, training status, and genetic predisposition likely influences the degree of molecular damage observed, highlighting the need for personalized approaches in exercise regimens and recovery strategies. Moreover, the parallels between the molecular signatures observed in endurance athletes and those in other models of oxidative stress – such as sepsis, aging, or even storage lesions in transfused blood – offer broader biological insights that could extend to clinical settings, including transfusion medicine. Finally, while the current study provides a comprehensive snapshot of the acute molecular responses to long-distance running, future longitudinal studies are needed to assess the persistence of these changes and to directly link molecular alterations to functional outcomes. Such work would not only deepen our understanding of exercise-induced cellular stress but also inform interventions aimed at preserving RBCs functionality and overall cardiovascular health in athletes.

Supplementary Material

Supplementary Methods and Figures
Supplementary Tables 1-6

Key points:

  • In vivo RBC damage resulting from ultra-running mirrors molecular damage accrued by RBC during ex vivo storage under blood bank conditions

  • Ultra-running accelerates RBC aging via inflammation, IL-6, kynurenine, oxidation, copper

Acknowledgments

Funding:

This work was supported by funds from the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI) awards R01HL146442, R01HL149714, R01HL148151 (AD), National Cancer Institute award R01CA292482 (TN), and National Institute on Aging awards U54AG062319 and R01AG089069 (TN).

Footnotes

Competing interests: AD, KCH, and TN are founders of Omix Technologies Inc. AD and TN are scientific advisory board members for Hemanext Inc. AD is a scientific advisory board member for Macopharma Inc and Synth-Med Biotechnologies. The remaining authors declare no competing financial interests.

Data and materials availability:

All data are available in the main text or the supplementary materials.

REFERENCES

  • 1.Mairbäurl H Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells. Frontiers in Physiology. 2013;4:332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yoshida T, Prudent M, D'Alessandro A. Red blood cell storage lesion: causes and potential clinical consequences. Blood Transfusion. 2019. [Google Scholar]
  • 3.D'Alessandro A, Hansen KC, Eisenmesser EZ, Zimring JC. Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage? Blood Transfus. 2019;17(4):281–288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hargreaves M, Spriet LL. Skeletal muscle energy metabolism during exercise. Nat Metab. 2020;2(9):817–828. [DOI] [PubMed] [Google Scholar]
  • 5.Amatori S, Sisti D, Bertuccioli A, et al. Are pre-race serum blood biomarkers associated with the 24-h ultramarathon race performance? European Journal of Sport Science. 2024;24(4):431–439. [Google Scholar]
  • 6.Siekierzycka A, Radulska A, Woźniak M, et al. Plasma cardiovascular stress biomarkers response to marathon running. Sports Medicine and Health Science. 2024. [Google Scholar]
  • 7.Nemkov T, Skinner SC, Nader E, et al. Acute Cycling Exercise Induces Changes in Red Blood Cell Deformability and Membrane Lipid Remodeling. Int J Mol Sci. 2021;22(2). [Google Scholar]
  • 8.San-Millán I, Stefanoni D, Martinez JL, Hansen KC, D’Alessandro A, Nemkov T. Metabolomics of Endurance Capacity in World Tour Professional Cyclists. Frontiers in Physiology. 2020;11:578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fleischer R Ueber eine neue form von haemoglobinurie beim menschen. Berl Klin Wschr. 1881;18:691. [Google Scholar]
  • 10.Gartner A, Dombrowski N, Lowe N, Behzadpour V, Zackula R. Foot-strike Hemolysis: A Scoping Review of Long-Distance Runners. Kans J Med. 2024;17(5):119–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nash D, Hughes MG, Butcher L, et al. IL-6 signaling in acute exercise and chronic training: Potential consequences for health and athletic performance. Scand J Med Sci Sports. 2023;33(1):4–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Northoff H, Berg A. Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med. 1991;12 Suppl 1:S9–15. [DOI] [PubMed] [Google Scholar]
  • 13.Nader E, Monedero D, Robert M, et al. Impact of a 10 km running trial on eryptosis, red blood cell rheology, and electrophysiology in endurance trained athletes: a pilot study. European Journal of Applied Physiology. 2020;120(1):255–266. [DOI] [PubMed] [Google Scholar]
  • 14.Robert M, Stauffer E, Nader E, et al. Impact of Trail Running Races on Blood Viscosity and Its Determinants: Effects of Distance. Int J Mol Sci. 2020;21(22). [Google Scholar]
  • 15.Skinner S, Nader E, Stauffer E, et al. Differential impacts of trail and ultra-trail running on cytokine profiles: An observational study. Clin Hemorheol Microcirc. 2021;78(3):301–310. [DOI] [PubMed] [Google Scholar]
  • 16.Contrepois K, Wu S, Moneghetti KJ, et al. Molecular Choreography of Acute Exercise. Cell. 2020;181(5):1112–1130.e1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Howe CCF, Alshehri A, Muggeridge D, et al. Untargeted Metabolomics Profiling of an 80.5 km Simulated Treadmill Ultramarathon. Metabolites. 2018;8(1). [Google Scholar]
  • 18.Stander Z, Luies L, Mienie LJ, et al. The unaided recovery of marathon-induced serum metabolome alterations. Sci Rep. 2020;10(1):11060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Høeg TB, Chmiel K, Warrick AE, Taylor SL, Weiss RH. Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance. Sports (Basel). 2020;8(4). [Google Scholar]
  • 20.Mairbäurl H Red blood cells in sports: Effects of exercise and training on oxygen supply by red blood cells. Frontiers in Physiology. 2013;4. [Google Scholar]
  • 21.Nemkov T, Reisz JA, Gehrke S, Hansen KC, D'Alessandro A. High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods. Methods in Molecular Biology (Clifton, NJ). 2019;1978:13–26. [Google Scholar]
  • 22.Reisz JA, Zheng C, D'Alessandro A, Nemkov T. Untargeted and Semi-targeted Lipid Analysis of Biological Samples Using Mass Spectrometry-Based Metabolomics. Methods in Molecular Biology (Clifton, NJ). 2019;1978:121–135. [Google Scholar]
  • 23.Stephenson D, Nemkov T, Qadri SM, Sheffield WP, D'Alessandro A. Inductively-Coupled Plasma Mass Spectrometry-Novel Insights From an Old Technology Into Stressed Red Blood Cell Physiology. Front Physiol. 2022;13:828087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.D'Alessandro A, Dzieciatkowska M, Nemkov T, Hansen KC. Red blood cell proteomics update: is there more to discover? Blood Transfus. 2017;15(2):182–187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pang Z, Zhou G, Ewald J, et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 2022;17(8):1735–1761. [DOI] [PubMed] [Google Scholar]
  • 26.Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2019;36(8):2628–2629. [Google Scholar]
  • 28.Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830–1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bahou WF, Marchenko N, Nesbitt NM. Metabolic Functions of Biliverdin IXβ Reductase in Redox-Regulated Hematopoietic Cell Fate. Antioxidants. 2023;12(5):1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Paukovich N, Xue M, Elder JR, et al. Biliverdin Reductase B Dynamics Are Coupled to Coenzyme Binding. J Mol Biol. 2018;430(18 Pt B):3234–3250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chen Y, Zhang J, Cui W, Silverstein RL. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med. 2022;219(6). [Google Scholar]
  • 32.Manfredi TG, Fielding RA, O'Reilly KP, Meredith CN, Lee HY, Evans WJ. Plasma creatine kinase activity and exercise-induced muscle damage in older men. Med Sci Sports Exerc. 1991;23(9):1028–1034. [PubMed] [Google Scholar]
  • 33.Nemkov T, Stephenson D, Erickson C, et al. Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo. Blood. 2024;143(5):456–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bizjak DA, Stangl M, Börner N, et al. Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics. Front Immunol. 2022;13:1004545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dewulf JP, Martin M, Marie S, et al. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci Rep. 2022;12(1):9959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Thomas T, Stefanoni D, Reisz JA, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5(14). [Google Scholar]
  • 37.Carreño M, Pires MF, Woodcock SR, et al. Immunomodulatory actions of a kynurenine-derived endogenous electrophile. Sci Adv. 2022;8(26):eabm9138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lang E, Lang F. Triggers, Inhibitors, Mechanisms, and Significance of Eryptosis: The Suicidal Erythrocyte Death. BioMed Research International. 2015;2015:1–16. [Google Scholar]
  • 39.Nader E, Guillot N, Lavorel L, et al. Eryptosis and hemorheological responses to maximal exercise in athletes: Comparison between running and cycling. Scandinavian Journal of Medicine & Science in Sports. 2018;28(5):1532–1540. [DOI] [PubMed] [Google Scholar]
  • 40.Nemkov T, Qadri SM, Sheffield WP, D'Alessandro A. Decoding the metabolic landscape of pathophysiological stress-induced cell death in anucleate red blood cells. Blood Transfusion. 2020. [Google Scholar]
  • 41.Wu H, Bogdanov M, Zhang Y, et al. Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease. Sci Rep. 2016;6:29637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.D'Alessandro A, Le K, Lundt M, et al. Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease. Haematologica. 2024;109(8):2639–2652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Nemkov T, Sun K, Reisz JA, et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica. 2018;103(2):361–372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chen C, Xie T, Zhang Y, et al. Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model. J Am Soc Nephrol. 2023;34(10):1647–1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nemkov T, Sun K, Reisz JA, et al. Metabolism of Citrate and Other Carboxylic Acids in Erythrocytes As a Function of Oxygen Saturation and Refrigerated Storage. Frontiers in Medicine. 2017;4:175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.D'Alessandro A, Fu X, Kanias T, et al. Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity. Haematologica. 2020:haematol.2020.246603. [Google Scholar]
  • 47.Francis RO, D'Alessandro A, Eisenberger A, et al. Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion. J Clin Invest. 2020;130(5):2270–2285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Reisz JA, Nemkov T, Dzieciatkowska M, et al. Methylation of protein aspartates and deamidated asparagines as a function of blood bank storage and oxidative stress in human red blood cells. Transfusion. 2018;58(12):2978–2991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Lv Z, Yuan L, Atkison JH, Aldana-Masangkay G, Chen Y, Olsen SK. Domain alternation and active site remodeling are conserved structural features of ubiquitin E1. J Biol Chem. 2017;292(29):12089–12099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Shenkin A Trace elements and inflammatory response: implications for nutritional support. Nutrition. 1995;11(1 Suppl):100–105. [PubMed] [Google Scholar]
  • 51.Adams KF, Johnson G Jr., Hornowski KE, Lineberger TH. The effect of copper on erythrocyte deformability: a possible mechanism of hemolysis in acute copper intoxication. Biochim Biophys Acta. 1979;550(2):279–287. [DOI] [PubMed] [Google Scholar]
  • 52.Robach P, Boisson RC, Vincent L, et al. Hemolysis induced by an extreme mountain ultra-marathon is not associated with a decrease in total red blood cell volume. Scand J Med Sci Sports. 2014;24(1):18–27. [DOI] [PubMed] [Google Scholar]
  • 53.Rapido F, Brittenham GM, Bandyopadhyay S, et al. Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest. 2017;127(1):375–382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48(3):143–153. [DOI] [PubMed] [Google Scholar]
  • 55.Syllm-Rapoport I, Daniel A, Starck H, Hartwig A, Gross J. Creatine in density-fractionated red cells, a useful indicator of erythropoietic dynamics and of hypoxia past and present. Acta Haematol. 1981;66(2):86–95. [DOI] [PubMed] [Google Scholar]
  • 56.Ku CP, Passow H. Creatine and creatinine transport in old and young human red blood cells. Biochim Biophys Acta. 1980;600(1):212–227. [DOI] [PubMed] [Google Scholar]
  • 57.Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A. 1998;95(6):3077–3081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Reinhart WH, Staubli M, Straub PW. Impaired red cell filterability with elimination of old red blood cells during a 100-km race. Journal of Applied Physiology. 1983;54(3):827–830. [DOI] [PubMed] [Google Scholar]
  • 59.Yusof A, Leithauser RM, Roth HJ, Finkernagel H, Wilson MT, Beneke R. Exercise-induced hemolysis is caused by protein modification and most evident during the early phase of an ultraendurance race. J Appl Physiol (1985). 2007;102(2):582–586. [DOI] [PubMed] [Google Scholar]
  • 60.Krumm B, Raberin A, Citherlet T, et al. Accelerated Red Blood Cell Turnover Following Extreme Mountain Ultramarathon? Med Sci Sports Exerc. 2025;57(5):904–911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Peltier S, Marin M, Dzieciatkowska M, et al. Proteostasis and metabolic dysfunction characterize a subset of storage-induced senescent erythrocytes targeted for post-transfusion clearance. J Clin Invest. 2025. [Google Scholar]
  • 62.Klei TR, Meinderts SM, van den Berg TK, van Bruggen R. From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis. Front Immunol. 2017;8:73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Telford RD, Sly GJ, Hahn AG, Cunningham RB, Bryant C, Smith JA. Footstrike is the major cause of hemolysis during running. J Appl Physiol (1985). 2003;94(1):38–42. [DOI] [PubMed] [Google Scholar]
  • 64.Chatzinikolaou PN, Margaritelis NV, Paschalis V, et al. Erythrocyte Glycolytic and Redox Metabolism Affects Muscle Oxygenation and Exercise Performance: A Randomized Double-Blind Crossover Study in Men. Sports Medicine. 2025. [Google Scholar]
  • 65.Yamada T, Tohori M, Ashida T, Kajiwara N, Yoshimura H. Comparison of effects of vegetable protein diet and animal protein diet on the initiation of anemia during vigorous physical training (sports anemia) in dogs and rats. J Nutr Sci Vitaminol (Tokyo). 1987;33(2):129–149. [DOI] [PubMed] [Google Scholar]
  • 66.Beneke R, Bihn D, Hütler M, Leithäuser RM. Haemolysis caused by alterations of alpha- and beta-spectrin after 10 to 35 min of severe exercise. Eur J Appl Physiol. 2005;95(4):307–312. [DOI] [PubMed] [Google Scholar]
  • 67.Smith JA. Exercise, Training and Red Blood Cell Turnover:. Sports Medicine. 1995;19(1):9–31. [DOI] [PubMed] [Google Scholar]
  • 68.Platt OS, Lux SE, Nathan DG. Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity. J Clin Invest. 1981;68(3):631–638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.van Beaumont W, Underkofler S, van Beaumont S. Erythrocyte volume, plasma volume, and acid-base changes in exercise and heat dehydration. Journal of Applied Physiology. 1981;50(6):1255–1262. [DOI] [PubMed] [Google Scholar]
  • 70.Lipovac V, Gavella M, Turk Z, Škrabalo Z. Influence of lactate on the insulin action on red blood cell filterability. Clinical Hemorheology and Microcirculation. 2016;5(5):421–428. [Google Scholar]
  • 71.Smith JA, Telford RD, Kolbuch-Braddon M, Weidemann MJ. Lactate/H+ uptake by red blood cells during exercise alters their physical properties. European Journal of Applied Physiology and Occupational Physiology. 1997;75(1):54–61. [DOI] [PubMed] [Google Scholar]
  • 72.Connes P, Bouix D, Py G, et al. Opposite effects of in vitro lactate on erythrocyte deformability in athletes and untrained subjects. Clinical Hemorheology and Microcirculation. 2004;31(4):311–318. [PubMed] [Google Scholar]
  • 73.Lands WE. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. The Journal of Biological Chemistry. 1958;231(2):883–888. [PubMed] [Google Scholar]
  • 74.Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. The Journal of Biological Chemistry. 1992;267(18):12673–12681. [PubMed] [Google Scholar]
  • 75.Arduini A, Rossi M, Mancinelli G, et al. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sciences. 1990;47(26):2395–2400. [DOI] [PubMed] [Google Scholar]
  • 76.Arduini A, Tyurin V, Tyuruna Y, et al. Acyl-trafficking in membrane phospholipid fatty acid turnover: The transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytes. Biochemical and Biophysical Research Communications. 1992;187(1):353–358. [DOI] [PubMed] [Google Scholar]
  • 77.Nemkov T, Key A, Stephenson D, et al. Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro. Blood. 2024. [Google Scholar]
  • 78.Annous KF, Song WO. Pantothenic acid uptake and metabolism by red blood cells of rats. The Journal of Nutrition. 1995;125(10):2586–2593. [DOI] [PubMed] [Google Scholar]
  • 79.Mian SA, Philippe C, Maniati E, et al. Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia. Sci Transl Med. 2023;15(685):eabn5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Williams MH. Vitamin supplementation and athletic performance. International Journal for Vitamin and Nutrition Research Supplement = Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung Supplement. 1989;30:163–191. [PubMed] [Google Scholar]
  • 81.Webster MJ. Physiological and performance responses to supplementation with thiamin and pantothenic acid derivatives. European Journal of Applied Physiology. 1998;77(6):486–491. [Google Scholar]
  • 82.Forbes LM, Cendali FI, Nemkov T, et al. Red Blood Cell Metabolic Responses during Acute Hypoxic Exercise in Healthy Adults. Am J Respir Cell Mol Biol. 2025;72(4):456–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Barber AA, Bernheim F. Lipid peroxidation: its measurement, occurrence, and significance in animal tissues. Adv Gerontol Res. 1967;2:355–403. [PubMed] [Google Scholar]
  • 84.Kim W, Deik A, Gonzalez C, et al. Polyunsaturated Fatty Acid Desaturation Is a Mechanism for Glycolytic NAD(+) Recycling. Cell Metab. 2019;29(4):856–870.e857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Thomas T, Cendali F, Fu X, et al. Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality. Transfusion. 2021. [Google Scholar]
  • 86.Carin R, Nader E, Bouscaren N, et al. Effects of Three Different Distance/Elevation Gain Ultra-Trail Races on Red Blood Cell Oxidative Stress and Senescence, and Blood Rheology. Med Sci Sports Exerc. 2025;57(6):1081–1091. [DOI] [PubMed] [Google Scholar]
  • 87.Adele BO, Idama C, Ige AO, Odetola AO, Emediong IE, Adewoye EO. Alterations in plasma and erythrocyte membrane fatty acid composition following exposure to toxic copper level affect membrane deformability and fluidity in female wistar rats. J Trace Elem Med Biol. 2023;80:127316. [DOI] [PubMed] [Google Scholar]
  • 88.Li H, Lu L, Li X, et al. Mechanics of diseased red blood cells in human spleen and consequences for hereditary blood disorders. Proceedings of the National Academy of Sciences. 2018;115(38):9574–9579. [Google Scholar]
  • 89.Powers RK, Culp-Hill R, Ludwig MP, et al. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Nat Commun. 2019;10(1):4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Zheng H, Teague TK, Yeh FC, et al. C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder. Brain Behav Immun. 2022;105:180–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Thomas T, Stefanoni D, Dzieciatkowska M, et al. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients. Journal of Proteome Research. 2020;19(11):4455–4469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Bizjak DA, John L, Matits L, et al. SARS-CoV-2 Altered Hemorheological and Hematological Parameters during One-Month Observation Period in Critically Ill COVID-19 Patients. Int J Mol Sci. 2022;23(23). [Google Scholar]
  • 93.Nader E, Nougier C, Boisson C, et al. Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Am J Hematol. 2022;97(3):283–292. [DOI] [PubMed] [Google Scholar]
  • 94.D’Alessandro A Red blood cell metabolism: a window on systems health towards clinical metabolomics. Current Opinion in Hematology. 2025;32(3):111–119. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Methods and Figures
Supplementary Tables 1-6

Data Availability Statement

All data are available in the main text or the supplementary materials.

RESOURCES